Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)

AstraZeneca3,300 enrolled

Overview

To evaluate the level of control of Asthma (GINA : controlled, partially controlled, not controlled) of asthmatic patients consulting their general practitioner for a seasonal increase of respiratory symptoms (high and / or low) whether an inhaled corticotherapy is taken or not.

Study Type

OBSERVATIONAL

Enrollment

3,300

Conditions

Asthma Respiratory Symptoms

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Asthmatic adults consulting for a seasonal increase of respiratory symptoms (high/low) and treated with PRN fast acting bronchodilator alone or associated with inhaled IGCS, excluding all other treatments for asthma.

Locations (1051)

Outcomes

Primary Outcomes

Evaluate the control level of Asthma of asthmatic patients consulting their GP for a seasonal increase of respiratory symptoms (high/low) with an inhaled corticotherapy or not.

Time frame: One shot (patients will only have one visit to attend - this visit will take place between May 09 and September 09)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Research Site

Abbaretz, France

Research Site

Acheux-en-Amiénois, France

Research Site

Agen, France

Research Site

Agneaux, France

Research Site

Agon-Coutainville, France

Research Site

Aignay-le-Duc, France

Research Site

Aiguillon, France

Research Site

Aiserey, France

Research Site

Aix-en-Provence, France

Research Site

Aix-les-Bains, France

...and 1041 more locations